{"title": "Subjects", "author": null, "url": null, "hostname": null, "description": "The Pharmaceutical Journal from the Royal Pharmaceutical Society", "sitename": "The Pharmaceutical Journal", "date": "2023-01-01", "cleaned_text": "Haematology - Haemic and lymphatic diseases - Hallucinogens - Health and care policy - Health communication and promotion - Health Education and Improvement Wales - Health Education England - Health inequalities - Health literacy - Health services administration - Health technology assessors - Healthcare informatics - Healthcare provision - Healthy living pharmacy - Heart failure - Heart health - Hepatitis B - Hepatitis C - History - HIV - HIV Pharmacy Association - HIV- Faculty - Homecare - Homeopathy - Hospital doctor - Hospital pharmacy - HP. Competences for pharmacists working in hospital practice - HP1. Planning pharmaceutical care for individual patients - HP10. Promoting quality and improving practice - HP10a. Contributing to the clinical governance agenda - HP10b. Managing risk - HP10c. Managing/embracing change - HP10d. Utilising the skills of other staff (skill mix) - HP10e. Training and developing staff - HP10f. Adopting reflective practice - HP10g. Recognising responsibility and accountability HP10h - HP10l. Participating in clinical audit HP10m - HP10o. Undertaking performance review of staff - HP10p. Reducing medication errors - HP10q. Learning from errors - HP10r. Contributing to the development of quality standards - HP11. Managing formularies, guidelines and protocols - HP11a. Developing formularies, guidelines and protocols in liaison with medical staff, nursing staff and other pharmacy colleagues - HP11b. Ensuring that stocks of medicines held in treatment areas conform to the formulary - HP11c. Ensuring that procedures are in place for the supply of formulary and non-formulary items - HP11d. Reviewing formularies, guidelines and protocols in collaboration with medical, nursing and pharmacy staff - HP11e. Ensuring that deviation from a formulary, clinical guideline or treatment protocol is the result of an active decision which involves the pharmacist - HP12. Working across professional and organisational boundaries - HP12a. Working/liaising with primary care - HP12b. Providing support to prescribers, eg reviewing repeat prescribing - HP12c. Using and contributing to shared records - HP12d. Providing intermediate care services - HP12e. Providing palliative care services, eg to hospices - HP12f. Developing joint care protocols - HP12g. Working with NHS agencies - HP12h. Working with sectors other than healthcare - HP13 . Reviewing and developing services - HP13a. Reviewing services - HP13b. Developing new services - HP13c. Developing 'whole system' prescribing - HP13d. Redesigning processes - HP13e. Redesigning medicines supply, eg original pack dispensing, automation - HP13f. Improving procurement systems - HP14. Producing, using and maintaining records; using information technology - HP14a. Using information technology, eg electronic records - HP14b. Compiling information on patients' current and past drug treatments - HP14c. Documenting a medication history/profile HP14d - HP15. Undertaking specialised activities - HP15a. Supplementary prescribing (see separate competences for supplementary prescribers) - HP15b. Participating in, or running, outpatient clinics - HP15c. Producing aseptic and cytotoxic products in a specialised unit - HP15d. Preparing sterile and non-sterile products extemporaneously in a licensed production unit - HP15e. Managing an aseptic or production unit - HP15f. Working in, or running, a quality assurance service - HP15g. Preparing products for clinical trials - HP15h. Preparing radiopharmaceuticals - HP1a. Assessing the individual patient's pharmaceutical needs - HP1b. Conducting a structured patient interview - HP1c. Compiling a medication history/medication profile - HP1d. Taking account of the patient's medication history/profile and clinical records - HP1e. Taking account of risk factors (w.r.t. the patient and the medication) - HP1f. Liaising with other members of the patient's healthcare team - HP1g. Selecting, or advising on, suitable medication, dose, route, frequency, timing and duration - HP1h. Monitoring the patient's progress and outcomes - HP1i. Reviewing, monitoring and updating the pharmaceutical care plan - HP1j. Recording the pharmaceutical care plan and the advice given to the patient and members of the healthcare team - HP2. Providing medicines information and advice - HP2a. Keeping up-to-date with new products and therapeutic advances - HP2b. Anticipating and identifying the need for evaluated drug information to support formulary review or individual patient care - HP2c. Establishing the background to requests for drug information and advice from healthcare professionals and patients - HP2d. Participating in the education and training of other healthcare professionals - HP2e. Advising on the legal and ethical considerations of using medicines in ways which are not covered by a product licence - HP2f. Liaising with others in regard to clinical trials in progress in the ward or unit - HP2g. Providing advice on pharmaceutical aspects of clinical trial design, eg to research and ethical committees - HP3. Promoting the safety, efficacy and cost-effectiveness of medicines - HP3a. Reviewing prescribing - HP3b. Reviewing patients' medication, eg on admission - HP3c. Educating and training other healthcare professionals on the safe and effective use of medicines - HP3d. Training, advising and counselling patients and carers in medicines taking - HP3e. Educating groups, eg patient groups, school children - HP3f. Providing information leaflets and other written information - HP3g. Assessing and prioritising the education and counselling needs of patients - HP3h. Monitoring patients' understanding of information provided - HP3i. Recording education and counselling activities - HP3j. Training other healthcare staff to provide education and counselling on the use of medicines and appliances - HP3k. Involving patients and carers in the audit of education and counselling services - HP3l. Assessing future medicines cost pressures - HP4. Monitoring prescriptions - HP5. Identifying and managing risk to patients - HP5a. Ensuring that prescribing for individual patients takes account of predictable adverse effects - HP5b. Ensuring that unnecessary drug use is avoided - HP5c. Individualising drug dosage requirements - HP5d. Identifying risk factors specific to the patient, eg their characteristics; social, environmental, functional, cognitive; aspects of their disease - HP5e. Identifying risk factors in relation to the patient's medication, eg toxicity, availability, bio-availability, administration issues - HP5f. Ensuring that patients receive cautionary and advisory labels and appropriate counselling in relation to the use of their medication - HP5g. Identifying patients who will require close monitoring of their medicines administration - HP5h. Educating and training pharmacy staff and other healthcare staff on the prevention, detection and reporting of ADRs - HP5i. Monitoring patients for adverse reactions, including delayed effects - HP5j. Participating in therapeutic drug monitoring - HP5k. Using all sources of information that may be helpful in detecting and monitoring ADRs - HP5l. Reporting, and encouraging others to report, ADRs - HP5m. Monitoring patients for iatrogenic disease - HP6. Optimising medicines administration - HP6a. Ensuring medication is administered correctly - HP6b. Developing/managing self-administration schemes - HP6c. Training staff involved in the administration of medicines - HP7. Promoting health - HP7a. Providing health education information - HP7b. Promoting healthy lifestyles and increasing awareness of current issues and guidelines - HP7c. Screening for chronic conditions - HP7d. Planning and managing vaccination and immunisation programmes - HP7e. Participating in measures to minimise the spread of communicable diseases, eg in relation to travellers, sexual practices, drug misuse - HP7f. Contributing to health protection initiatives - HP8. Evaluating medicines use - HP8a. Identifying medicines which are suitable for medicines use evaluation - HP8b. Defining acceptable standards for medicines use, with objective and measurable criteria - HP8c. Measuring and documenting outcomes against the standards HP8d - HP9. Managing transfer to another healthcare setting - HP9a. Collaborating with professionals to whom responsibility for the patient is to be transferred - HP9b. Taking account of shared care protocols - HP9c. Ensuring the patient receives appropriate counselling and advice on discharge - HP9d. Writing/reviewing the discharge prescription - HP9e. Reviewing the pharmaceutical care plan for the patient - HP9f. Making arrangements for the necessary medicines, dressings and appliances to be supplied on time - HP9g. Documenting the discharge/transfer and pharmaceutical care plans - HP9h. Transferring information between the healthcare settings - Human rights - Hygiene - Hypersensitivity and allergy - Hypertension "}